Variant report
| Variant | nsv9853 | 
|---|---|
| Chromosome Location | chr21:15342342-15349727 | 
| allele | n/a | 
| Outlinks | Ensembl   UCSC | 
- TF binding region (count:83)
 - CpG islands (count:0)
 - Chromatin interactive region (count:0)
 - LncRNA region (count:2)
 - Mature miRNA region (count: 0)
 - miRNA target sites (count:0)
 
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites | 
|---|---|---|---|---|---|---|
| 1 | ARID3A | chr21:15346022-15346251 | K562 | blood: | n/a | n/a | 
| 2 | ARID3A | chr21:15346922-15347270 | K562 | blood: | n/a | n/a | 
| 3 | ATF1 | chr21:15342677-15342811 | K562 | blood: | n/a | n/a | 
| 4 | BACH1 | chr21:15347039-15347218 | K562 | blood: | n/a | n/a | 
| 5 | BHLHE40 | chr21:15347507-15347656 | K562 | blood: | n/a | n/a | 
| 6 | CEBPB | chr21:15346232-15346412 | K562 | blood: | n/a | n/a | 
| 7 | CEBPB | chr21:15347031-15347099 | K562 | blood: | n/a | n/a | 
| 8 | CEBPD | chr21:15346361-15346742 | K562 | blood: | n/a | n/a | 
| 9 | CTCF | chr21:15347521-15347536 | K562 | blood: | n/a | n/a | 
| 10 | CUX1 | chr21:15347059-15347236 | K562 | blood: | n/a | n/a | 
| 11 | CUX1 | chr21:15345847-15346152 | K562 | blood: | n/a | n/a | 
| 12 | EP300 | chr21:15343658-15343948 | GM12878 | blood: | n/a | n/a | 
| 13 | EP300 | chr21:15347518-15347687 | K562 | blood: | n/a | n/a | 
| 14 | EP300 | chr21:15347044-15347244 | K562 | blood: | n/a | n/a | 
| 15 | EP300 | chr21:15345798-15346486 | K562 | blood: | n/a | n/a | 
| 16 | EP300 | chr21:15346910-15347275 | K562 | blood: | n/a | chr21:15346958-15346972 | 
| 17 | FOS | chr21:15342273-15342644 | MCF10A-Er-Src | breast: | n/a | n/a | 
| 18 | FOS | chr21:15342189-15342590 | MCF10A-Er-Src | breast: | n/a | n/a | 
| 19 | FOS | chr21:15342307-15342560 | MCF10A-Er-Src | breast: | n/a | n/a | 
| 20 | FOS | chr21:15342162-15342590 | MCF10A-Er-Src | breast: | n/a | n/a | 
| 21 | FOXA1 | chr21:15342267-15342442 | T-47D | breast: | n/a | n/a | 
| 22 | FOXA1 | chr21:15342243-15342442 | T-47D | breast: | n/a | n/a | 
| 23 | FOXA2 | chr21:15342198-15342551 | A549 | lung: | n/a | n/a | 
| 24 | FOXA2 | chr21:15342193-15342634 | A549 | lung: | n/a | n/a | 
| 25 | GATA1 | chr21:15342574-15342957 | K562 | blood: | n/a | chr21:15342814-15342821 chr21:15342814-15342821 chr21:15342812-15342822 chr21:15342811-15342823 chr21:15342814-15342821 | 
| 26 | GATA2 | chr21:15347387-15347724 | K562 | blood: | n/a | n/a | 
| 27 | GATA2 | chr21:15346916-15347369 | K562 | blood: | n/a | chr21:15347170-15347180 chr21:15347197-15347207 chr21:15347240-15347249 | 
| 28 | GATA2 | chr21:15346320-15346885 | K562 | blood: | n/a | chr21:15346659-15346669 chr21:15346715-15346722 chr21:15346558-15346566 chr21:15346660-15346669 chr21:15346715-15346722 chr21:15346660-15346667 chr21:15346715-15346722 | 
| 29 | HEY1 | chr21:15347452-15347641 | K562 | blood: | n/a | n/a | 
| 30 | IRF1 | chr21:15346896-15347628 | K562 | blood: | n/a | chr21:15347039-15347059 | 
| 31 | IRF1 | chr21:15345815-15346434 | K562 | blood: | n/a | chr21:15345992-15346006 chr21:15345996-15346010 chr21:15345998-15346007 chr21:15345990-15346007 chr21:15345996-15346006 | 
| 32 | IRF1 | chr21:15345805-15346158 | K562 | blood: | n/a | chr21:15345992-15346006 chr21:15345996-15346010 chr21:15345998-15346007 chr21:15345990-15346007 chr21:15345996-15346006 | 
| 33 | IRF1 | chr21:15346431-15346451 | K562 | blood: | n/a | n/a | 
| 34 | IRF1 | chr21:15347030-15347251 | K562 | blood: | n/a | chr21:15347039-15347059 | 
| 35 | JUN | chr21:15347051-15347251 | K562 | blood: | n/a | n/a | 
| 36 | JUN | chr21:15345896-15346304 | K562 | blood: | n/a | n/a | 
| 37 | JUND | chr21:15346904-15347256 | K562 | blood: | n/a | n/a | 
| 38 | JUND | chr21:15342350-15342485 | HepG2 | liver: | n/a | n/a | 
| 39 | JUND | chr21:15347521-15347548 | K562 | blood: | n/a | n/a | 
| 40 | JUND | chr21:15345893-15346210 | K562 | blood: | n/a | n/a | 
| 41 | JUND | chr21:15342153-15342508 | A549 | lung: | n/a | n/a | 
| 42 | MAFF | chr21:15346885-15347268 | K562 | blood: | n/a | n/a | 
| 43 | MAFK | chr21:15345893-15346097 | K562 | blood: | n/a | n/a | 
| 44 | MAFK | chr21:15346903-15347260 | K562 | blood: | n/a | chr21:15347087-15347096 | 
| 45 | MAZ | chr21:15345967-15346136 | K562 | blood: | n/a | n/a | 
| 46 | MAZ | chr21:15347075-15347217 | K562 | blood: | n/a | n/a | 
| 47 | MYC | chr21:15342353-15342568 | MCF10A-Er-Src | breast: | n/a | n/a | 
| 48 | MYC | chr21:15342313-15342563 | MCF10A-Er-Src | breast: | n/a | n/a | 
| 49 | MYC | chr21:15346235-15346562 | K562 | blood: | n/a | chr21:15346500-15346509 | 
| 50 | MYC | chr21:15346856-15347086 | K562 | blood: | n/a | n/a | 
| No data | 
| No data | 
          
 (count:2 , 50 per page) page: 
       
          
               
                   
                    1
                   
                   
                   
                   
                
          
         
    
| No. | lncRNA name | Chromosome Location | lncRNA alias | 
|---|---|---|---|
| 1 | lnc-LIPI-4 | chr21:15342294-15342431 | NONHSAT081133 | 
| 2 | lnc-LIPI-4 | chr21:15344317-15344450 | NONHSAT081133 | 
| No data | 
| No data | 
| Variant related genes | Relation type | 
|---|---|
| RNU6-954P | TF binding region | 
| ANKRD20A11P | TF binding region | 
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits | 
|---|---|---|---|---|---|---|---|
| 1 | rs565611673 | chr21:15342344-15342345 | Enhancers Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a | 
| 2 | rs384047 | chr21:15342395-15342396 | Enhancers Weak transcription | TF binding regionlncRNA | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 3 | rs184237485 | chr21:15342425-15342426 | Enhancers Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a | 
| 4 | rs568109234 | chr21:15342448-15342449 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 5 | rs537717638 | chr21:15342455-15342456 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 6 | rs557402757 | chr21:15342471-15342472 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 7 | rs577480497 | chr21:15342491-15342492 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 8 | rs556101427 | chr21:15342516-15342517 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 9 | rs546050076 | chr21:15342518-15342519 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 10 | rs553531733 | chr21:15342520-15342521 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 11 | rs573213239 | chr21:15342551-15342552 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 12 | rs187531101 | chr21:15342561-15342562 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 13 | rs384202 | chr21:15342572-15342573 | Enhancers Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 14 | rs530843351 | chr21:15342592-15342593 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 15 | rs191565262 | chr21:15342609-15342610 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 16 | rs143281241 | chr21:15342637-15342638 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 17 | rs563403601 | chr21:15342649-15342650 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 18 | rs532460311 | chr21:15342655-15342656 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 19 | rs552040383 | chr21:15342695-15342696 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 20 | rs572158157 | chr21:15342757-15342758 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 21 | rs565877660 | chr21:15342776-15342777 | Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 22 | rs377579067 | chr21:15342863-15342864 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 23 | rs528185086 | chr21:15342880-15342881 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 24 | rs113009968 | chr21:15342885-15342886 | Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a | 
| 25 | rs59271677 | chr21:15342905-15342906 | Weak transcription | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 26 | rs61018900 | chr21:15342967-15342968 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a | 
| 27 | rs554892639 | chr21:15342994-15342995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 28 | rs537008985 | chr21:15343034-15343035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 29 | rs4816883 | chr21:15343068-15343069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 30 | rs4816884 | chr21:15343069-15343070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 31 | rs554027669 | chr21:15343091-15343092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 32 | rs556936520 | chr21:15343100-15343101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 33 | rs571009100 | chr21:15343107-15343108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 34 | rs4816885 | chr21:15343112-15343113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 35 | rs561826207 | chr21:15343117-15343118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 36 | rs574127767 | chr21:15343155-15343156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 37 | rs374768405 | chr21:15343161-15343162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 38 | rs76199574 | chr21:15343182-15343183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 39 | rs4816886 | chr21:15343187-15343188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 40 | rs149164878 | chr21:15343195-15343196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 41 | rs553279190 | chr21:15343197-15343198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 42 | rs370965149 | chr21:15343204-15343205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 43 | rs367831145 | chr21:15343213-15343214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 44 | rs371467949 | chr21:15343226-15343227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 45 | rs374616499 | chr21:15343235-15343236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 46 | rs190048015 | chr21:15343239-15343240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 47 | rs374600274 | chr21:15343252-15343253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 48 | rs535535123 | chr21:15343259-15343260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 49 | rs555477405 | chr21:15343306-15343307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| 50 | rs75866591 | chr21:15343320-15343321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a | 
| Disease | PMID | Source | 
|---|---|---|
| Ovarian cancer | 21720365 | CNVD | 
| Wilms tumour | 21544195 | CNVD | 
| Esophageal cancer | 21851588 | CNVD | 
| Glioblastoma multiforme | 21080181 | CNVD | 
| Cancer | 16751803 | CNVD | 
| Medulloblastoma | 21979893 | CNVD | 
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD | 
| Down syndrome | 17412756 | CNVD | 
| Down syndrome | 17576883 | CNVD | 
| Acute promyelocytic leukemia | 19109227 | CNVD | 
| T-cell prolymphocytic leukemia | 17713554 | CNVD | 
| Autism | 22495311 | CNVD | 
| Lung cancer | 18438408 | CNVD | 
| Acute lymphoblastic leukemia | 17690704 | CNVD | 
| Sudden cardiac death | 19188705 | CNVD | 
| T-cell prolymphocytic leukemia | 19278963 | CNVD | 
| Acute myeloid leukemia | 20729466 | CNVD | 
| Acute lymphoblastic leukemia | 20435627 | CNVD | 
| Breast cancer | 21509527 | CNVD | 
| T-cell lymphomas | 19863542 | CNVD | 
| Non-small cell lung cancer | 21044232 | CNVD | 
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD | 
| Astrocytoma | 17387387 | CNVD | 
| Endometrial cancer | 22040021 | CNVD | 
| Breast cancer | 21264507 | CNVD | 
| Glioblastoma multiforme | 17387387 | CNVD | 
| Renal cell carcinoma | 19461508 | CNVD | 
| Seminomas | 18059402 | CNVD | 
| Chronic lymphocytic leukemia | 21546498 | CNVD | 
| Acute lymphoblastic leukemia | 21980252 | CNVD | 
| Metanephric adenoma | 20802469 | CNVD | 
| Neuroblastoma | 18923191 | CNVD | 
| Prostate cancer | 19156837 | CNVD | 
| Basal cell lymphoma | 17170743 | CNVD | 
| Follicular lymphoma | 17170743 | CNVD | 
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD | 
| Cancer | 20164919 | CNVD | 
| small cell lung cancer | 20016488 | CNVD | 
| Acute lymphoblastic leukemia | 21339820 | CNVD | 
| Breast cancer | 20409316 | CNVD | 
| Autism | 18414403 | CNVD | 
| Basal cell lymphoma | 16317097 | CNVD | 
| Diffuse large b-cell lymphoma | 16317097 | CNVD | 
| lymphocytic leukemia | 21291569 | CNVD | 
| Hodgkin''s lymphoma | 18641027 | CNVD | 
| Acute myeloid leukemia | 21251322 | CNVD | 
| abnormal development | 18461090 | CNVD | 
| Breast cancer | 21785460 | CNVD | 
| Breast cancer | 21364760 | CNVD | 
| Breast cancer | 22522925 | CNVD | 
| Multiple myeloma | 17550852 | CNVD | 
| Myelofibrosis | 22110671 | CNVD | 
| Alzheimer''s disease | 18923514 | CNVD | 
| Alzheimer''s disease | 20877625 | CNVD | 
| Follicular lymphoma | 20505157 | CNVD | 
| Alzheimer''s disease | 21956041 | CNVD | 
| Cancer | 21183584 | CNVD | 
| Non-syndromic sensorineural hearing loss | 15273396 | CNVD | 
| Invasive pancreatic ductal carcinoma | 16982739 | CNVD | 
| Melanoma | 18172304 | CNVD | 
| Autism | 22958593 | CNVD | 
| Schizophrenia | 22958593 | CNVD | 
| No. | Chromosome Location | Chromatin state | Cell line | Tissue | 
|---|---|---|---|---|
| 1 | chr21:15310400-15347400 | Weak transcription | Dnd41 | blood | 
| 2 | chr21:15341400-15342800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast | 
| 3 | chr21:15341400-15342800 | Enhancers | Hela-S3 | cervix | 
| 4 | chr21:15341400-15342800 | Enhancers | K562 | blood | 
| 5 | chr21:15342000-15342600 | Weak transcription | HMEC | breast | 
| 6 | chr21:15342600-15342800 | Enhancers | HMEC | breast | 
| 7 | chr21:15342800-15345800 | Weak transcription | K562 | blood | 
| 8 | chr21:15345800-15346400 | Flanking Active TSS | K562 | blood | 
| 9 | chr21:15346000-15346200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- | 
| 10 | chr21:15346400-15346800 | Enhancers | K562 | blood | 
| 11 | chr21:15346800-15347000 | Flanking Active TSS | K562 | blood | 
| 12 | chr21:15347000-15347200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- | 
| 13 | chr21:15347000-15347600 | Active TSS | K562 | blood | 
| 14 | chr21:15347400-15347600 | Enhancers | Esophagus | oesophagus | 
| 15 | chr21:15347400-15347800 | Enhancers | Dnd41 | blood | 
| 16 | chr21:15347600-15347800 | Flanking Active TSS | K562 | blood | 
| 17 | chr21:15347600-15351800 | Weak transcription | Esophagus | oesophagus | 
| 18 | chr21:15347800-15348600 | Weak transcription | K562 | blood | 
| 19 | chr21:15347800-15350000 | Weak transcription | Dnd41 | blood | 
| 20 | chr21:15348600-15349000 | Enhancers | K562 | blood | 
| 21 | chr21:15349000-15349800 | Weak transcription | K562 | blood | 






